Nirsevimab 50MG PFS 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FAUEC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,717
Award facts
- Contract value 100% obligated
- $12,716.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,716.52 to AmerSourceBergen Drug Corp for Nirsevimab 50 mg prefilled syringes on January 22, 2026, with an ultimate completion date of February 19, 2026. This firm fixed-price, non-set-aside contract is for delivery to the company's headquarters location in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Nirsevimab is a monoclonal antibody indicated for respiratory syncytial virus (RSV) prevention in infants and young children, and this procurement demonstrates the Defense Logistics Agency's ongoing efforts to supply preventive immunological treatments across the military healthcare system. AmerSourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, consistently fulfills delivery orders for a comprehensive range of pharmaceutical products across multiple therapeutic domains. The non-set-aside designation reflects the competitive award process through which AmerSourceBergen secured this delivery order, consistent with its substantial portfolio of federal pharmaceutical supply contracts.
Quick answers
Who was awarded contract SPE2DR26FAUEC?
SPE2DR26FAUEC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FAUEC worth?
The government has obligated $12,717 on SPE2DR26FAUEC.
Is contract SPE2DR26FAUEC an order under another contract?
Yes. SPE2DR26FAUEC is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAUEC competed?
The extent of competition for SPE2DR26FAUEC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award